Building interface 
Champions is constantly updating the data in our bank and as such, please reach out to your local BD contact to provide you with the most up-to-date information possible. We can readily provide customized, comprehensive, and easy to navigate spreadsheets to meet your needs so please do not hesitate to reach out to us at database@championsoncology.com.
| Cell Line | Tumor Type | Immunogenic | Pilot data | Treatments screened | Characterization (completed/proposed) | |
|---|---|---|---|---|---|---|
| 4T-1 | Breast | No; refractory | Yes | a-PD-1/a-CTLA-4/a-OX40 | Growth; T/B cells; MDSCs; macrophages | |
| MC38 | Colon | Yes | Yes | a-PD-1/a-CTLA-4/a-OX40 | Growth; T/B cells; MDSCs; macrophages; NK cells | |
| LLC | Lung | No; refractory | Yes | a-PD-1/a-CTLA-4/a-OX40 | Growth | |
| CT26 | Colon | Yes | Yes | a-PD-1/a-CTLA-4/a-OX40 | Growth | |
| B16F10 | Melanoma | Partially | Yes | a-PD-1/a-CTLA-4/a-OX40 | Growth | |
| RENCA | Kidney | TBD | No | a-PD-1/a-CTLA-4/a-OX40 | Proposed: growth; T/B cells; MDSCs; macrophages, NK cells |